These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 38167873)
1. Increased risk of hearing loss associated with macrolide use: a systematic review and meta-analysis. Shim SR; Lee Y; In SM; Lee KI; Kim I; Jeong H; Shin J; Kim JY Sci Rep; 2024 Jan; 14(1):183. PubMed ID: 38167873 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Adverse events in people taking macrolide antibiotics versus placebo for any indication. Hansen MP; Scott AM; McCullough A; Thorning S; Aronson JK; Beller EM; Glasziou PP; Hoffmann TC; Clark J; Del Mar CB Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011825. PubMed ID: 30656650 [TBL] [Abstract][Full Text] [Related]
4. Macrolide antibiotics for bronchiectasis. Kelly C; Chalmers JD; Crossingham I; Relph N; Felix LM; Evans DJ; Milan SJ; Spencer S Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012406. PubMed ID: 29543980 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis. Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349 [TBL] [Abstract][Full Text] [Related]
6. Sensorineural hearing loss with macrolide antibiotics exposure: a meta-analysis of the association. Alsowaida YS; Almulhim AS; Oh M; Erstad B; Abraham I Int J Pharm Pract; 2021 Feb; 29(1):21-28. PubMed ID: 32871046 [TBL] [Abstract][Full Text] [Related]
7. Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides. Gorelik E; Masarwa R; Perlman A; Rotshild V; Muszkat M; Matok I Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610207 [TBL] [Abstract][Full Text] [Related]
8. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591 [TBL] [Abstract][Full Text] [Related]
9. Macrolide-associated ototoxicity: a cross-sectional and longitudinal study to assess the association of macrolide use with tinnitus and hearing loss. Vanoverschelde A; Oosterloo BC; Ly NF; Ikram MA; Goedegebure A; Stricker BH; Lahousse L J Antimicrob Chemother; 2021 Sep; 76(10):2708-2716. PubMed ID: 34312676 [TBL] [Abstract][Full Text] [Related]
12. Platinum-induced hearing loss after treatment for childhood cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010181. PubMed ID: 27486906 [TBL] [Abstract][Full Text] [Related]
13. Different infusion durations for preventing platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2020 Jan; 1(1):CD010885. PubMed ID: 31961948 [TBL] [Abstract][Full Text] [Related]
14. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Anglemyer A; Horvath HT; Bero L Cochrane Database Syst Rev; 2014 Apr; 2014(4):MR000034. PubMed ID: 24782322 [TBL] [Abstract][Full Text] [Related]
15. Different infusion durations for preventing platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010885. PubMed ID: 29975402 [TBL] [Abstract][Full Text] [Related]
16. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156 [TBL] [Abstract][Full Text] [Related]
18. Different infusion durations for preventing platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2016 Aug; (8):CD010885. PubMed ID: 27498707 [TBL] [Abstract][Full Text] [Related]
19. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737 [TBL] [Abstract][Full Text] [Related]
20. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]